Feds Still Investigating Whether Biomet Broke Rules Abroad
The U.S. Department of Justice and the U.S. Securities and Exchange Commission are continuing to investigate "alleged improprieties" by medical device company Biomet Inc. in Brazil and Mexico to determine whether...To view the full article, register now.
Already a subscriber? Click here to view full article